Fibrin Sealants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Hemostasis and tissue sealing agents are medical devices utilized to control bleeding during surgical procedures. Fibrin was the first modern hemostatic agent approved for use in the U.S. in 1998. Fibrin sealant is the only commercially available FDA-approved material for clinical use as a hemostat, sealant, and adhesive. Fibrin sealants are referred as most adopted hemostats worldwide. Flowable hemostatic agents are thick fibrin sealants, flowable, consistency products, which comprise two chief components, one active and the other passive, that convert fibrinogen to fibrin at the site of bleeding. The passive component is either bovine or porcine gelatin, while the active component is thrombin. Thrombin addition to gelatin may not be required in certain cases. Advancements in hemostasis technology has led to development of wide range of products that have enabled clinicians to provide proper emergency assistance to patients. Hemostatic products include thrombin sealants, fibrin glue, bovine serum/albumin/glutaraldehyde, gelatin matrix, microfibrillar collagen matrix, and oxidized regenerated cellulose. Each of these agents differ in mechanism, application, and cost. Fibrin sealant can be applied in liquid form or as a patch. However, liquid fibrin presents a challenge of being cumbersome to use due to its preparatory steps of thawing, mixing, etc. Hence, patches have become far convenient for use as hemostatic agents. Baxter Healthcare’s Tisseel and TachoSil, Orthovita, Inc.’s Vitagel, and Ethicon US, LLC’s Evicel and Evarrest are the prominent fibrin sealant based hemostatic products in the market. Tisseel has been used in Europe for more than 25 years and has been used for over 9.5 million surgical procedures including cardiac, splenic trauma, and colon anastomosis surgery. Evicel has been approved by the U.S. FDA for hemostasis in liver surgery.
The patient pool with different chronic diseases is also growing rapidly across the world. This is likely to increase the number of surgical procedures, consequently propelling the fibrin sealants market in the near future. Strict but inconsistent regulatory policies across the world are creating an apprehensive environment among the market players, thereby restraining the fibrin sealants market. According to the National Hemophilia Foundation, over 400,000 people suffer from hemophilia globally. However, only about 176,000 are accurately identified. Factor VIII forms an indispensable treatment option for such patients. Large unmet needs of the undiagnosed population is likely to propel the fibrin sealants market. Increase in number of trauma cases, rise in geriatric population, surge in surgical procedures, high number of patients with blood-related disorders such as hemophilia, and expanding product portfolios are the major drivers of the fibrin sealants market.
The global fibrin sealants market can be segmented based on type of product, end-user, and region. In terms of type of product, the market can be classified into liquid form, patch, and others. New product launch of sealants across the world is projected to boost the growth of the global fibrin sealants market. Based on end-user, the global fibrin sealants market can be categorized into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment is expected to account for the largest share of the market.
The global fibrin sealants market can be segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America and Europe are expected to dominate the market due to high number of surgeries carried out in these regions. According to data released by the Centers for Disease Control and Prevention (CDC), the prevalence rate of hemophilia in the U.S. is 1 in every 5000 male births. Von Willebrand disease (VWD), another bleeding disorder, is the most commonly occurring blood disorder that affects 1% of the population of the U.S. The hemostasis products market in Asia Pacific offers significant opportunities in the next few years. Growth of the market is attributed to large patient pool with underserved requirements along with rapidly growing population, and rise in investments by market players in this region.
The global fibrin sealants market is fragmented, with presence of small number of key players. These include Baxter International, CSL Behring, and Johnson & Johnson Services, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017